WO2022088014A1 - Composition for skincare - Google Patents
Composition for skincare Download PDFInfo
- Publication number
- WO2022088014A1 WO2022088014A1 PCT/CN2020/125138 CN2020125138W WO2022088014A1 WO 2022088014 A1 WO2022088014 A1 WO 2022088014A1 CN 2020125138 W CN2020125138 W CN 2020125138W WO 2022088014 A1 WO2022088014 A1 WO 2022088014A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycol
- composition
- weight
- monoalcohol
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Definitions
- the present invention relates to a composition.
- the present invention relates to a composition for skincare.
- the present invention also relates to a non-therapeutic method for caring for the skin, and use of the combination of at least one C5-C10 glycol and at least one linear unsaturated C18-C30 monoalcohol for improving the penetration of a water soluble cosmetic active ingredient into the skin.
- the skin is the protective barrier for the human body. It protects the interior of the body from physical injury (such as trauma) and biological injury (such as bacteria, viruses or fungi) .
- the skin of the human body comprises the dermis and the epidermis.
- the epidermis is the topmost layer of the skin, and its superficial layer is called the stratum corneum.
- JP-A-2011-73992 discloses a composition
- a composition comprising the following components (A) to (F) : (A) 10-50 parts by weight of one or more polyglycerin fatty acid esters with an HLB of 10-18, obtained from a polyglycerin and a fatty acid having 8 to 22 carbon atoms, (B) 1-30 parts by weight of one or more fatty acid monoglycerides obtained from glycerin and a fatty acid having 8 to 22 carbon atoms, (C) 0.1-30 parts by weight of an oil in the form of liquid at 25°C., (D) 10-35 parts by weight of a polyhydric alcohol, (E) 5-40 parts by weight of water, and (F) 0.01-10 parts by weight of a ceramide.
- A 10-50 parts by weight of one or more polyglycerin fatty acid esters with an HLB of 10-18, obtained from a polyglycerin and a fatty acid having 8 to 22 carbon atoms
- B 1-30
- WO 2005/065630 A1 discloses a monophase micro-emulsion composition
- a monophase micro-emulsion composition comprising (A) a hydrophilic nonionic surfactant, (B) a lipophilic nonionic surfactant, (C) oil, (D) an aqueous solvent immiscible with the oil, in which the critical micell concentration (c. m. c) of hydrophilic nonionic surfactant is higher than that in water, and (E) water.
- WO 2004/045566 discloses a semitransparent cosmetic consisting of an O/W emulsion which comprises (a) a ceramide, (b) an oil component, (c) a nonionic surfactant, and (d) water and has a mean particle diameter of 100 to 300 nm.
- compositions containing cosmetic active ingredient for caring for keratin materials it is difficult for the active ingredient contained to penetrate into the keratin materials.
- compositions containing cosmetic active ingredients For compositions containing cosmetic active ingredients, penetration of the active ingredients to the stratum corneum is one of the most important properties.
- compositions having an improved effect in terms of penetration of the cosmetic active ingredient contained to the stratum corneum.
- the present invention relates to a composition for skincare, comprising in a hydrophilic phase:
- composition of the present invention can be in the form of an emulsion or a liquid, for example, a toner or a serum.
- the present invention relates to a non-therapeutic method for caring for the skin, comprising applying the composition according to the first aspect of the present invention to the skin.
- hydrophilic cosmetic active ingredient contained in the composition according to the present invention can easily penetrate into the stratum corneum.
- the present invention relates to use of the combination of at least one C5-C6 glycol and at least one linear unsaturated C18-C30 monoalcohol for improving the penetration of a hydrophilic cosmetic active ingredient into the skin.
- Fig. 1 shows the Raman spectra of 400-2000cm -1 for niacinamide.
- Fig. 2 shows the Raman spectra of 400-2000cm -1 for proxylane.
- Fig. 3 shows the penetration profile of niacinamide and proxylane for the composition of background 1.
- Fig. 4 shows the penetration profile of niacinamide and proxylane for the composition of background 2.
- Fig. 5 shows the penetration profile of niacinamide and proxylane for the composition of comparative formula 1
- Fig. 6 shows the penetration profile of niacinamide and proxylane for the composition of comparative formula 2
- Fig. 7 shows the penetration profile of niacinamide and proxylane for the composition of comparative formula 3
- Fig. 8 shows the penetration profile of niacinamide and proxylane for the composition of invention formula 1;
- Fig. 9 shows a comparison of penetration profile of niacinamide for the compositions of comparative formulas 1-3 and invention formula 1;
- Fig. 10 shows a comparison of penetration profile of proxylane for the compositions of comparative formulas 1-3 and invention formula 1.
- the present invention provides a composition for skincare, comprising, in a hydrophilic phase:
- composition of the present invention comprises a hydrophilic phase.
- the hydrophilic phase comprises at least one solvent selected from water and C2-C4 glycol.
- the hydrophilic phase comprises at least one organic solvent miscible with water (at room temperature 25°C) such as for example monoalcohols having from 2 to 6 carbon atoms such as ethanol, isopropanol, triols such as glycerin.
- organic solvent miscible with water at room temperature 25°C
- monoalcohols having from 2 to 6 carbon atoms such as ethanol, isopropanol, triols such as glycerin.
- the hydrophilic phase of the composition of the present invention comprises water and glycerin.
- water is preferably present in the composition of the present invention in an amount ranging from 1%to 80%by weight, preferably from 5%to 77%by weight, more preferably from 10%to 75%by weight, relative to the total weight of the composition.
- Said hydrophilic phase is preferably present in an amount ranging from 10%to 99%by weight, more preferably from 20%to 90%by weight, and even more preferably from 50%to 85%by weight of the total weight of the composition.
- the composition of the present invention comprises at least one C5-C10 glycol.
- the glycol has 5-8 carbon atoms, i.e, being C5-C8 glycol.
- the glycol is selected from C5-C6glycol.
- the composition of the present invention comprises at least one C5-C8 glycol, preferably C5-C6 glycol.
- C5-C10 glycols that can be used in the composition of the present invention, mention can be made to pentylene glycol, hexylene glycol, dipropylene glycol, heptanediol, octanediol, nonanediol, and decylene glycol.
- glycols includes all possible isomers.
- pentylene glycol comprises 1, 5-pentylene glycol, 2, 4-pentylene glycol, etc.
- the composition comprises pentylene glycol.
- the C5-C10 glycol is present in an amount ranging from 0.1%to 10%, preferably from 0.2%to 5%by weight, more preferably from 0.5%to 3%by weight, relative to the total weight of the composition.
- composition of the present invention comprises at least one linear unsaturated C18-C30 monoalcohol.
- the linear unsaturated C18-C30 monoalcohol is of structure R-OH with R denoting a linear alkenyl group comprising from 18 to 30 carbon atoms.
- the linear unsaturated C18-C30 monoalcohol is selected from monoalcohol of structure R-OH with R denoting a linear alkenyl comprising from 18 to 24 carbon atoms.
- the linear unsaturated C18-C30 monoalcohol is oleyl alcohol.
- the linear unsaturated C18-C30 monoalcohol is present in an amount ranging from 0.1%to 10%, preferably from 1%to 10%by weight, more preferably from 2%to 8%by weight, relative to the total weight of the composition.
- the composition of the present invention comprises at least one hydrophilic cosmetic active ingredient.
- hydrophilic cosmetic active ingredient means cosmetic active ingredient soluble or disperable in the hydrophilic phase defined above.
- hydrophilic cosmetic active ingredient mention can be made of:
- Ecamsule phenylbenzimidazole sulfonic acid
- Ensulizole phenylbenzimidazole sulfonic acid
- Benzophenone-4 aminobenzoic acid
- camphor benzalkonium methosulfate methylene bis-benzotriazolyl tetramethylbutylphenol (Bisoctrizole) , disodium phenyl dibenzimidazole tetrasulfonate (Bisdisulizole disodium) , tris-biphenyl triazine; their derivatives and corresponding salts; naphthaline bisimide derivatives, and cinnamido amine cationic quaternary salts and derivatives, and mixtures thereof;
- -proxylane hydroxypropyl tetrahydropyrantriol
- flavones flavones
- stilbenoids tannins
- phenolic acids polyphenolics
- vitamins, xanthines, ceramides, cholesterols, sphingosines, C-glycosides zwitterionic N-substituted amino sulfonic acid buffers
- sugars nucleic acids, a-and ⁇ -hydroxy acids, aminopropyl triethoxysilane, dihydroxyacetone, botanical extracts, amino acids, and peptides, their derivatives, and combinations thereof
- nucleic acids nucleic acids
- a-and ⁇ -hydroxy acids aminopropyl triethoxysilane
- dihydroxyacetone botanical extracts, amino acids, and peptides, their derivatives, and combinations thereof
- -ascorbic acid and its biologically compatible salts, enzymes, antibiotics, components having a tautening effect alpha. -hydroxy acids and their salts, hydroxylated polyacids, sucroses and their derivatives, urea, amino acids, oligopeptides, carnosine, acetyl tetrapeptide-9, palmitoyl tripeptide-1, water-soluble plant and yeast extracts, protein hydrolysates, hyaluronic acid, mucopolysaccharides, vitamins B 2 , B 3 (niacinamide) , B 6 , H and PP, panthenol, folic acid, acetylsalicylic acid, allantoin, glycyrrhetic acid, kojic acid and hydroquinone.
- the hydrophilic cosmetic active ingredient is selected from proxylane (hydroxypropyl tetrahydropyrantriol) , niacinamide, and a mixture thereof.
- the hydrophilic cosmetic active ingredient is present in an amount ranging from 0.1%to 40%by weight, preferably from 1 to 35%by weight, more preferably from 10%to 35%by weight, relative to the total weight of the composition.
- composition of the present invention further comprises a fatty phase.
- Said fatty phase preferably comprises at least one oil.
- the oil can be volatile or non-volatile.
- oil means a water-immiscible non-aqueous compound that is liquid at room temperature (25°C) and at atmospheric pressure (760 mmHg) .
- non-volatile oil means an oil that may remain on keratin materials at room temperature and atmospheric pressure for at least several hours and that especially has a vapour pressure of less than 10 -3 mmHg (0.13 Pa) .
- a non-volatile oil may also be defined as having an evaporation rate such that, under the conditions defined previously, the amount evaporated after 30 minutes is less than 0.07 mg/cm 2 .
- oils may be of plant, mineral or synthetic origin.
- said oil is selected from hydrocarbonated, silicone or fluorinated oils.
- hydrocarbon-based oil or “hydrocarbonated oil” means an oil formed essentially from, or even constituted by, carbon and hydrogen atoms, and optionally O and N atoms, and free of Si and F heteroatoms.
- Such oil can contain alcohol, ester, ether, carboxylic acid, amine and/or amide groups.
- silicon oil means an oil containing at least one silicon atom, especially containing Si-O groups.
- fluorinated oil means an oil containing at least one fluorine atom.
- the fatty phase can be, for example, present in an amount ranging from 0.01%to 50%by weight, preferably from 0.05%to 30%by weight, more preferably from 0.1%to 10%by weight, relative to the total weight of the composition.
- composition of the present invention may comprise conventional cosmetic adjuvants or additives, for instance fragrances, chelating agents (for example, disodium EDTA) , preserving agents (for example, chlorphenesin and phenoxyethanol) and bactericides, surfactants, thickeners, fillers, pH regulators (for example citric acid, sodium hydroxide, potassium hydroxide) , and mixtures thereof.
- fragrances for instance, fragrances, chelating agents (for example, disodium EDTA) , preserving agents (for example, chlorphenesin and phenoxyethanol) and bactericides, surfactants, thickeners, fillers, pH regulators (for example citric acid, sodium hydroxide, potassium hydroxide) , and mixtures thereof.
- chelating agents for example, disodium EDTA
- preserving agents for example, chlorphenesin and phenoxyethanol
- bactericides for example, surfactants, thickeners, fillers, pH regulators (for example citric acid, sodium
- the present invention provides a composition for skincare, comprising in a hydrophilic phase, relative to the total weight of the composition:
- the present invention relates to a non-therapeutic method for caring for the skin, comprising applying the composition according to the first aspect of the present invention to the skin.
- the keratin material is the skin.
- the present invention provides a non-therapeutic method for caring for the skin, comprising applying the composition according to the first aspect of the present invention to the skin.
- the present invention relates to use of the combination of at least one C5-C10 glycol and at least one linear unsaturated C18-C30 monoalcohol for improving the penetration of a hydrophilic cosmetic active ingredient into the skin.
- the C5-C10 glycol and the linear unsaturated C18-C30 monoalcohol are defined as above.
- the at least one C5-C10 glycol is selected from C 5 -C 8 glycol
- the at least one linear unsaturated C18-C30 monoalcohol is selected from monoalcohol of structure R-OH with R denoting a linear alkenyl comprising from 18 to 24 carbon atoms.
- the at least one C5-C10 glycol is pentylene glycol
- the at least one linear unsaturated C18-C30 monoalcohol is oleyl oil.
- the hydrophilic cosmetic active ingredient is selected from proxylane, niacinamide, and a mixture thereof.
- compositions according to comparative formulas (Comp. ) and invention formula (Inv. ) were prepared according to the contents given in Table 1 (the contents are expressed as weight percentages of active material relative to the total weight of each composition, unless otherwise indicated) .
- Composition of comparative formula 1 does not comprise C5-C10 glycol and linear unsaturated C18-C30 monoalcohol.
- Composition of comparative formula 2 does not comprise C5-C10 glycol.
- Composition of comparative formula 3 does not comprise linear unsaturated C18-C30 monoalcohol.
- compositions were also prepared as baseline compositions for baselines for Raman spectroscopy test described below according to the contents given in Table 2 (the contents are expressed as weight percentages of active material relative to the total weight of each composition, unless otherwise indicated) .
- compositions listed above were prepared as follows, taking the composition of invention formula 1 as an example:
- composition of each formula was applied evenly on 0.8cm X 0.8cm porcine skin (pig ear skin from food industry) , corresponding to 9 mg/cm 2 .
- porcine skin sample was then emerged on insert membrane with PBS underneath, followed by 37°C incubation at 95%RH for 2 hours.
- Treated sample was embedded in an OCT Tissue Freezing Medium, then frozen and cryo-sectioned into 20 ⁇ m thickness. It was further placed on a CaF2 substrate for Raman confocal scanning.
- Three porcine samples were prepared for each formula. A Raman confocal mapping was acquired of each treated sample.
- Raman confocal microscope was used. Raman spectrum was obtained using a 532 nm DPSS laser with a power of 8 mW on the sample, coupled with a ⁇ 50 LM Plan objective (Olympus, NA 0.75, Rungis, France) . The confocal hole was set at 100 ⁇ m diameterfor all measurements. The system was spectrally calibrated to the 520.7 cm -1 spectral line of silicon before the test. Detection was facilitated by dispersing Raman-shifted radiation onto a charge-coupled device (CCD) detector using a grating of 600 lines/mm.
- CCD charge-coupled device
- the step size was 3 ⁇ m in both X and Y direction.
- the acquisition areas were 18 X 150 ⁇ m.
- 50%laser intensity and 5 seconds acquisition time per spectrum was used.
- Spectral range was 400-2000cm -1 .
- Non-negative constrained least square (NCLS) analysis was performed using Matlab. Before statistical analysis, Raman spectra were subjected to a linear baseline correction. Cosmetic active ingredient spectral of 400-2000cm -1 fingerprints were used for analysis.
- Fig. 1 shows the Raman spectra of 400-2000cm -1 for niacinamide.
- Fig. 2 shows the Raman spectra of 400-2000cm -1 for proxylane.
- NCLS outcome A simplified description of the NCLS outcome can be defined as:
- SRi Raman signal of each suppositional ingredient (PCA component) in untreated porcine;
- Ci coefficient of each suppositional ingredient (PCA component) in the exact pixel
- the computational co-efficient index of active ingredients can be used to generate the distribution profile of ACIs from outer skin stratum corneum to the deeper dermis part.
- Fig. 3 shows the penetration profile of niacinamide and proxylane for the composition of background 1.
- Fig. 4 shows the penetration profile of niacinamide and proxylane for the composition of background 2.
- Fig. 5 shows the penetration profile of niacinamide and proxylane for the composition of comparative formula 1.
- Fig. 6 shows the penetration profile of niacinamide and proxylane for the composition of comparative formula 2
- Fig. 7 shows the penetration profile of niacinamide and proxylane for the composition of comparative formula 3
- Fig. 8 shows the penetration profile of niacinamide and proxylane for the composition of invention formula 1;
- Fig. 9 shows a comparison of penetration profile of niacinamide for the compositions of comparative formulas 1-3 and invention formula 1;
- Fig. 10 shows a comparison of penetration profile of proxylane for the compositions of comparative formulas 1-3 and invention formula 1.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (15)
- A composition for skincare, comprising in a hydrophilic phase:(i) at least one C5-C10 glycol;(ii) at least one linear unsaturated C18-C30 monoalcohol; and(iii) at least one hydrophilic cosmetic active ingredient.
- Composition according to claim 1, wherein the C5-C10 glycol is selected from pentylene glycol, hexylene glycol, dipropylene glycol, heptanediol, octanediol, nonanediol, and decylene glycol.
- Composition according to claim 1 or 2, wherein the C5-C10 glycol is present in an amount ranging from 0.1%to 10%, preferably from 0.2%to 5%by weight, more preferably from 0.5%to 3%by weight, relative to the total weight of the composition.
- Composition according to any of claims 1 to 3, wherein the linear unsaturated C18-C30 monoalcohol is of structure R-OH with R denoting a linear alkenyl group comprising from 18 to 30 carbon atoms.
- Composition according to any of claims 1 to 4, wherein the linear unsaturated C18-C30 monoalcohol is selected from linear monoalcohols having from 18 to 24 carbon atoms.
- Composition according to any of claims 1 to 5, wherein the linear unsaturated C18-C30 monoalcohol is present in an amount ranging from 0.1%to 10%, preferably from 1%to 10%by weight, more preferably from 2%to 8%by weight, relative to the total weight of the composition.
- Composition according to any of claims 1 to 6, wherein the hydrophilic cosmetic active ingredient is present in an amount ranging from 0.1%to 40%, preferably from 1 to 35%by weight, more preferably from 10%to 35%by weight, relative to the total weight of the composition.
- Composition according to any of claims 1 to 7, further comprising conventional cosmetic adjuvants or additives selected from fragrances, chelating agents, preserving agents, bactericides, surfactants, thickeners, fillers, pH regulators, and mixtures thereof.
- Composition according to claim 1, comprising in a hydrophilic phase, relative to the total weight of the composition:(i) from 0.5%to 3%by weight of pentylene glycol;(ii) from 2%to 8%by weight of oleyl alcohol; and(iii) from 10%to 35%by weight of at least one hydrophilic cosmetic active ingredient selected from proxylane, niacinamide, and a mixture thereof.
- Composition according to any of claims 1-9, wherein the hydrophilic phase comprises at least one solvent selected from water and C2-C4 glycol.
- A non-therapeutic method for caring for the skin, comprising applying the composition according to any of claims 1-10 to the skin.
- Use of the combination of at least one C5-C10 glycol and at least one linear unsaturated C18-C30 monoalcohol for improving the penetration of a hydrophilic cosmetic active ingredient into the skin.
- Use according to claim 12, wherein the at least one C5-C10 glycol is selected from C5-C8 glycol, and the at least one linear unsaturated C18-C30 monoalcohol is selected from monoalcohol of structure R-OH with R denoting a linear alkenyl comprising from 18 to 24 carbon atoms.
- Use according to claim 12, wherein the at least one C5-C10 glycol is pentylene glycol, and the at least one linear unsaturated C18-C30 monoalcohol is oleyl oil.
- Use according to claim 13 or 14, wherein the hydrophilic cosmetic active ingredient is selected from proxylane, niacinamide, and a mixture thereof.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2020/125138 WO2022088014A1 (en) | 2020-10-30 | 2020-10-30 | Composition for skincare |
| KR1020237010772A KR20230054893A (en) | 2020-10-30 | 2020-10-30 | Composition for skin care |
| CN202080106873.4A CN116367809A (en) | 2020-10-30 | 2020-10-30 | Skin care composition |
| US18/250,308 US20230404891A1 (en) | 2020-10-30 | 2020-10-30 | Composition for skincare |
| JP2023525584A JP2023546979A (en) | 2020-10-30 | 2020-10-30 | Composition for skin care |
| EP20959176.7A EP4236907A4 (en) | 2020-10-30 | 2020-10-30 | COMPOSITION FOR SKIN CARE |
| FR2100338A FR3115691B1 (en) | 2020-10-30 | 2021-01-14 | Skin care composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2020/125138 WO2022088014A1 (en) | 2020-10-30 | 2020-10-30 | Composition for skincare |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022088014A1 true WO2022088014A1 (en) | 2022-05-05 |
Family
ID=81383498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2020/125138 Ceased WO2022088014A1 (en) | 2020-10-30 | 2020-10-30 | Composition for skincare |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230404891A1 (en) |
| EP (1) | EP4236907A4 (en) |
| JP (1) | JP2023546979A (en) |
| KR (1) | KR20230054893A (en) |
| CN (1) | CN116367809A (en) |
| FR (1) | FR3115691B1 (en) |
| WO (1) | WO2022088014A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025118179A1 (en) * | 2023-12-06 | 2025-06-12 | L'oreal | Composition for caring for and/or making up keratin materials |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102946223B1 (en) * | 2020-12-22 | 2026-04-01 | 로레알 | Composition for brightening and/or whitening of keratin substances |
| WO2025107117A1 (en) * | 2023-11-20 | 2025-05-30 | L'oreal | Cosmetic composition with a c-glycoside, niacinamide and panthenol |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130115173A1 (en) * | 2011-11-03 | 2013-05-09 | Precision Dermatology, Inc. | Stable Dermatological Aerosol Foams Utilizing Reactive Propellants |
| WO2014098267A1 (en) * | 2012-12-21 | 2014-06-26 | L'oreal | Cosmetic composition |
| WO2018097303A1 (en) * | 2016-11-28 | 2018-05-31 | L'oreal | Composition in the form of nano- or micro- emulsion |
| CN111568782A (en) * | 2020-06-15 | 2020-08-25 | 花安堂生物科技集团有限公司 | Nanoemulsion composition capable of improving skin barrier and application thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62410A (en) * | 1985-06-25 | 1987-01-06 | Shiseido Co Ltd | Cosmetic |
| JPH02250813A (en) * | 1989-03-22 | 1990-10-08 | Kao Corp | Cosmetic |
| WO1991005736A1 (en) * | 1989-10-19 | 1991-05-02 | Shiseido Company, Ltd. | Hydrophilic polymer-silicate mineral composite and its use |
| JP3234041B2 (en) * | 1993-03-29 | 2001-12-04 | 株式会社資生堂 | External preparation for skin |
| JPH07238009A (en) * | 1994-02-24 | 1995-09-12 | Kao Corp | Skin protection cosmetics |
| JP3658626B2 (en) * | 1996-12-02 | 2005-06-08 | 白井松新薬株式会社 | Cosmetics and quasi drugs |
| CN1344151A (en) * | 1999-02-12 | 2002-04-10 | 宝洁公司 | Cosmetic composition containing vitamin B3 compounds |
| JP2003073229A (en) * | 2001-09-03 | 2003-03-12 | Asahi Kasei Corp | Spray containing cellulose |
| WO2004045566A1 (en) | 2002-11-15 | 2004-06-03 | Kose Corporation | Semitransparent cosmetics |
| JP3816877B2 (en) * | 2003-02-05 | 2006-08-30 | 有限会社セルリバース | Topical skin preparation |
| WO2004089087A1 (en) * | 2003-04-04 | 2004-10-21 | Shiseido Company Ltd. | Skin preparation composition for external use |
| JP2005132777A (en) * | 2003-10-30 | 2005-05-26 | Shiseido Co Ltd | Antimicrobial agent |
| US8461214B2 (en) | 2004-01-06 | 2013-06-11 | Shiseido Co., Ltd. | One-phase microemulsion compositions, O/W ultrafine emulsion external formulations and method for producing the same |
| JP2006256966A (en) * | 2005-03-15 | 2006-09-28 | Shiseido Co Ltd | External composition for skin |
| JP5608351B2 (en) | 2009-09-29 | 2014-10-15 | 太陽化学株式会社 | Ceramide-containing composition |
| JP6005900B2 (en) * | 2010-07-14 | 2016-10-12 | 株式会社アルソア本社 | Melanin production inhibitor and medicinal product, food or cosmetic having melanin production inhibitory action |
| US9511144B2 (en) * | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
| WO2015100118A1 (en) * | 2013-12-24 | 2015-07-02 | The Procter & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
| JP7102687B2 (en) * | 2017-06-02 | 2022-07-20 | 味の素株式会社 | External composition |
| JP6912772B2 (en) * | 2017-06-27 | 2021-08-04 | 日本精化株式会社 | Hyaluronic acid production promoter and cosmetics containing it |
| JP7195989B2 (en) * | 2019-03-25 | 2022-12-26 | 日本精化株式会社 | Erythritan derivative and cosmetics containing the same |
-
2020
- 2020-10-30 US US18/250,308 patent/US20230404891A1/en active Pending
- 2020-10-30 EP EP20959176.7A patent/EP4236907A4/en active Pending
- 2020-10-30 JP JP2023525584A patent/JP2023546979A/en active Pending
- 2020-10-30 WO PCT/CN2020/125138 patent/WO2022088014A1/en not_active Ceased
- 2020-10-30 KR KR1020237010772A patent/KR20230054893A/en not_active Ceased
- 2020-10-30 CN CN202080106873.4A patent/CN116367809A/en active Pending
-
2021
- 2021-01-14 FR FR2100338A patent/FR3115691B1/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130115173A1 (en) * | 2011-11-03 | 2013-05-09 | Precision Dermatology, Inc. | Stable Dermatological Aerosol Foams Utilizing Reactive Propellants |
| WO2014098267A1 (en) * | 2012-12-21 | 2014-06-26 | L'oreal | Cosmetic composition |
| WO2018097303A1 (en) * | 2016-11-28 | 2018-05-31 | L'oreal | Composition in the form of nano- or micro- emulsion |
| CN111568782A (en) * | 2020-06-15 | 2020-08-25 | 花安堂生物科技集团有限公司 | Nanoemulsion composition capable of improving skin barrier and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP4236907A4 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025118179A1 (en) * | 2023-12-06 | 2025-06-12 | L'oreal | Composition for caring for and/or making up keratin materials |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116367809A (en) | 2023-06-30 |
| EP4236907A4 (en) | 2024-07-24 |
| FR3115691A1 (en) | 2022-05-06 |
| US20230404891A1 (en) | 2023-12-21 |
| JP2023546979A (en) | 2023-11-08 |
| FR3115691B1 (en) | 2024-01-12 |
| KR20230054893A (en) | 2023-04-25 |
| EP4236907A1 (en) | 2023-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2727807C2 (en) | Local delivery of skin care compositions having low ph | |
| FR3045338B1 (en) | COMPOSITION COMPRISING AT LEAST TWO ESTERS OF FATTY ACID AND (POLY) GLYCEROL, AND USE THEREOF IN COSMETICS | |
| JP5798745B2 (en) | Topically applied cosmetic or pharmaceutical composition | |
| JP4918202B2 (en) | Skin composition | |
| JP7071357B2 (en) | Composition containing truffle extract and neohesperidin dihydrochalcone | |
| WO2022088014A1 (en) | Composition for skincare | |
| BR102022008827A2 (en) | BACTERIAL YEAST OF LACTOBACILLUS SPECIES | |
| TW200303763A (en) | Cosmetic and/or dermatological use of a composition comprising at least one oxidation-sensitive hydrophilic active principle stabilized by at least one N-vinylimidazole polymer or copolymer | |
| WO1993010804A1 (en) | Cosmetic or pharmaceutical composition containing a black horehound extract | |
| EP1753393B1 (en) | Method for the innoformulation of a biocompatible galenic base | |
| CN108135816A (en) | Compositions comprising dimethylisosorbide, polyols and phenolic or polyphenolic antioxidants for topical application | |
| CN113081903A (en) | Transparent whitening essence containing 4-butylresorcinol and preparation method thereof | |
| EP4134426A1 (en) | Novel bacterial ferment of lactobacillus species | |
| JP6654369B2 (en) | Elastase inhibitor | |
| FR3096582A1 (en) | Aqueous extract of grape marc from Château d'Yquem and uses | |
| CN114099410A (en) | Face cream composition with liposome with synergistic anti-aging effect and preparation method thereof | |
| JP2007532521A (en) | Use of sphingoid bases associated with nicotinic acid or nicotinamide in the form of depigmenting agents | |
| EP2150267B1 (en) | Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient | |
| JP7793549B2 (en) | Antimicrobial compositions for combating malodors | |
| JP2024046365A (en) | Transglutaminase production promoter and its use | |
| US20240299268A1 (en) | A composition for caring for keratin materials | |
| EP2370453B1 (en) | Peptides derived from hmg-coa reductase and cosmetic and/or pharmaceutical composition containing the same | |
| WO2016102400A1 (en) | Composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound and a specific solvent | |
| EP3366273B1 (en) | Moisturizer and cosmetic containing same | |
| FR2827764A1 (en) | Composition useful as a cosmetic product comprises a dehydroepiandrosterone compound and hexylene glycol or dipropylene glycol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20959176 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 20237010772 Country of ref document: KR Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023525584 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2020959176 Country of ref document: EP Effective date: 20230530 |
|
| WWR | Wipo information: refused in national office |
Ref document number: 1020237010772 Country of ref document: KR |
|
| WWR | Wipo information: refused in national office |
Ref document number: 1020237010772 Country of ref document: KR |
|
| WWC | Wipo information: continuation of processing after refusal or withdrawal |
Ref document number: 1020237010772 Country of ref document: KR |



